Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 69
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a new tissue preservation method inspired by Tardigrades

    There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...

    Finding a Cure for Batten Disease

    In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...

    Human placentophagy: What is the microbial composition of raw and processed placental tissue?

    Placentophagy is gaining in popularity as supporters of this behavior claim it has the ability to improve...

    Backer Badge Funded